High doses of the drug ivermectin, controversially recommended by some high-profile political and media figures during the COVID-19 pandemic, is ineffective at treating the COVID-19 virus, say University of Oxford- affiliated ...
Feb 22, 2023
1
69
Researchers are investigating whether the COVID virus can affect vision and depth-perception of those infected.
Dec 21, 2022
0
85
Following established guidelines about prescription drugs would seem to be an obvious course of action, especially for the professionals that do the prescribing. Yet doctors and their family members are less likely than other ...
Dec 16, 2022
0
300
Like Canadian Prime Minister Justin Trudeau and Mexican President Andrés Obrador before him, Prime Minister Anthony Albanese has been infected with COVID for a second time.
Dec 9, 2022
0
24
Cases of respiratory syncytial virus (RSV) are usually at their worst during the winter months. This year, however, has seen a marked increase of cases in the summer, leading to overcrowding in hospitals throughout the United ...
Dec 1, 2022
0
4
A study conducted in Brazil and reported in an article in Vaccines shows that in the São José do Rio Preto region in the northwest of São Paulo state, only 75.8% of children aged 0-15 have antibodies against measles. The ...
Dec 1, 2022
0
9
Researchers from the Centenary Institute and the University of Sydney have developed a new nasal vaccination strategy that induces potent lung immunity and protection against the SARS-CoV-2 coronavirus.
Nov 16, 2022
0
92
Rabbits co-infected with a respiratory bacterial infection and one or more gut helminth parasites are more likely to shed bacteria that can infect others, according to a report led by researchers at Penn State and published ...
Nov 8, 2022
0
10
By now more than 70% of the UK population have received a third COVID vaccination, or a booster. Many people who are older or at higher risk from COVID have had a fourth or even a fifth dose. But for how long and how often ...
Oct 24, 2022
0
5
Researchers have identified the gene TDRD7 as a key regulator against influenza A virus (IAV), which causes respiratory tract infections in 5 to 20 percent of the human population. These findings could facilitate the development ...
Oct 5, 2022
0
80
